| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 5 527-535, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
Y Sakai, KG Nelson, S Snedeker, NL Bossert, MP Walker, J McLachlan and RP DiAugustine
Laboratory of Reproductive and Developmental Toxicology, NIEHS, Research Triangle Park, North Carolina 27709.
There is a disparity in the fact that epidermal growth factor (EGF) can stimulate proliferation of a wide variety of cells in vitro, yet sites of synthesis for this polypeptide in vivo are generally associated with nonproliferative or differentiated cell populations. Unlike other known mitogenic members of the EGF family of ligands, EGF derives from a large (M(r) approximately 130,000) protein that contains multiple EGF-like domains; some of these domains contain putative Ca(2+)-binding sites. In the present study, the mouse vaginal epithelium was used as a prototype tissue to investigate expression of the EGF precursor by stratified squamous epithelia. Stratification and cornification in this tissue are estrogen dependent. In the fully differentiated epithelium, EGF precursor transcripts were detected by in situ hybridization in suprabasal cells; labeling was not observed in the proliferative basal cell compartment. Amplified transcripts of predicted size were detected in the vaginal organ by the reverse transcription-polymerase chain reaction and Northern hybridization of polyadenylated RNA. Antisera to mature EGF or to the COOH-terminal (cytoplasmic) domain of the precursor localized reactivity exclusively to cells of the granular layer. The staining with the precursor antiserum was localized along cell borders, which supports that this protein is translocated to the cell membrane following synthesis, a known property for precursors of EGF-like ligands. EGF expression was not apparent in the atrophic vaginal epithelium of castrates, which did not present a granular layer. Other stratified squamous epithelia in organs such as skin, esophagus, and tongue also revealed EGF/EGF precursor immunoreactivity in the granular layer.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
M. R. Schneider, S. Werner, R. Paus, and E. Wolf Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology Am. J. Pathol., July 1, 2008; 173(1): 14 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Wada-Hiraike, H. Hiraike, H. Okinaga, O. Imamov, R. P. A. Barros, A. Morani, Y. Omoto, M. Warner, and J.-A. Gustafsson Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta-/- mice PNAS, November 28, 2006; 103(48): 18350 - 18355. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems Endocr. Rev., December 1, 2003; 24(6): 737 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Morris-Wiman, R. Sego, L. Brinkley, and C. Dolce The Effects of Sialoadenectomy and Exogenous EGF on Taste Bud Morphology and Maintenance Chem Senses, February 1, 2000; 25(1): 9 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wakita and M. Takigawa Activation of Epidermal Growth Factor Receptor Promotes Late Terminal Differentiation of Cell-Matrix Interaction-disrupted Keratinocytes J. Biol. Chem., December 24, 1999; 274(52): 37285 - 37291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wiesen, P Young, Z Werb, and G. Cunha Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development Development, January 1, 1999; 126(2): 335 - 344. [Abstract] [PDF] |
||||
![]() |
Y. K. Hom, P. Young, J. F. Wiesen, P. J. Miettinen, R. Derynck, Z. Werb, and G. R. Cunha Uterine and Vaginal Organ Growth Requires Epidermal Growth Factor Receptor Signaling from Stroma Endocrinology, March 1, 1998; 139(3): 913 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Bellusci, J Grindley, H Emoto, N Itoh, and B. Hogan Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung Development, January 12, 1997; 124(23): 4867 - 4878. [Abstract] [PDF] |
||||
![]() |
S Bellusci, Y Furuta, M. Rush, R Henderson, G Winnier, and B. Hogan Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis Development, January 1, 1997; 124(1): 53 - 63. [Abstract] [PDF] |
||||
![]() |
G Q Zhao, K Deng, P A Labosky, L Liaw, and B L Hogan The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes & Dev., July 1, 1996; 10(13): 1657 - 1669. [Abstract] [PDF] |
||||
![]() |
S Bellusci, R Henderson, G Winnier, T Oikawa, and B. Hogan Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis Development, January 6, 1996; 122(6): 1693 - 1702. [Abstract] [PDF] |
||||
![]() |
L. Strachan, J. G. Murison, R. L. Prestidge, M. A. Sleeman, J. D. Watson, and K. D. Kumble Cloning and Biological Activity of Epigen, a Novel Member of the Epidermal Growth Factor Superfamily J. Biol. Chem., May 18, 2001; 276(21): 18265 - 18271. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |